Delayed graft function is not associated with an increased incidence of renal allograft rejection

Clinical Transplantation

Volumn 26, Issue 6, 2012, Pages

  Hirt Minkowski, Patricia ^a   Amico, Patrizia ^a   Hönger, Gideon ^a   Praehauser, Claudia ^a   Steiger, Jürg ^a   Koller, Michael T ^a   Gürke, Lorenz ^a   Mayr, Michael ^a   Schaub, Stefan ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acute rejection; Deceased donor; Delayed graft function; Renal transplantation; Subclinical rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; EVEROLIMUS; HLA ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; DELAYED GRAFT FUNCTION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; DELAYED GRAFT FUNCTION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84870687778     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12041     Document Type: Article

References (43)

1. Halloran PF, Hunsicker LG. Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001: 1: 115.
2. Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant 2011: 11: 2279.
3. Rosenthal JT, Danovitch GM, Wilkinson A, Ettenger RB. The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 1991: 51: 1115.
4. Almond PS, Troppmann C, Escobar F, Frey DJ, Matas AJ. Economic impact of delayed graft function. Transplant Proc 1991: 23: 1304.
5. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transpl 2005: 1.
6. Daly PJ, Power RE, Healy DA, Hickey DP, Fitzpatrick JM, Watson RW. Delayed graft function: a dilemma in renal transplantation. BJU Int 2005: 96: 498.
7. Cacciarelli T, Sumrani N, Delaney V, Hong JH, DiBenedetto A, Sommer BG. The influence of delayed renal allograft function on long-term outcome in the cyclosporine era. Clin Nephrol 1993: 39: 335.
8. Troppmann C, Gillingham KJ, Benedetti E et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995: 59: 962.
9. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997: 63: 968.
10. Shoskes DA, Cecka JM. Effect of delayed graft function on short- and long-term kidney graft survival. Clin Transpl 1997: 297.
11. Kyllonen LE, Salmela KT, Eklund BH et al. Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int 2000: 13: 122.
12. Marcen R, Orofino L, Pascual J et al. Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 1998: 66: 461.
13. Arias M. Impact of the delayed graft function in hypersensitized kidney transplant patients. Transplant Proc 2003: 35: 1655.
14. Cole E, Naimark D, Aprile M et al. An analysis of predictors of long-term cadaveric renal allograft survival. Clin Transplant 1995: 9: 282.
15. Gentil MA, Alcaide MP, Algarra GR et al. Impact of delayed graft function on cadaveric kidney transplant outcome. Transplant Proc 2003: 35: 689.
16. Moreso F, Seron D, Gil-Vernet S et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999: 14: 930.
17. Woo YM, Jardine AG, Clark AF et al. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 1999: 55: 692.
18. Rodrigo E, Fernandez-Fresnedo G, Ruiz JC et al. Similar impact of slow and delayed graft function on renal allograft outcome and function. Transplant Proc 2005: 37: 1431.
19. Howard RJ, Pfaff WW, Brunson ME et al. Increased incidence of rejection in patients with delayed graft function. Clin Transplant 1994: 8: 527.
20. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009: 24: 1039.
21. Amico P, Honger G, Mayr M, Steiger J, Hopfer H, Schaub S. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009: 87: 1681.
22. Amico P, Hirt-Minkowski P, Honger G et al. Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations. Transpl Int 2011: 24: 560.
23. Sis B, Mengel M, Haas M et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010: 10: 464.
24. Bachler K, Amico P, Honger G et al. Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies. Am J Transplant 2010: 10: 1254.
25. Loupy A, Suberbielle-Boissel C, Hill GS et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009: 9: 2561.
26. Dunn TB, Noreen H, Gillingham K et al. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant 2011: 11: 2132.
27. Lefaucheur C, Loupy A, Hill GS et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010: 21: 1398.
28. Bradley BA. Rejection and recipient age. Transpl Immunol 2002: 10: 125.
29. Denhaerynck K, Dobbels F, Cleemput I et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int 2005: 18: 1121.
30. Brennan DC, Daller JA, Lake KD, Cibrik D, Del CD. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006: 355: 1967.
31. Webster AC, Ruster LP, McGee R et al. Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev 2010: CD003897.
32. Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007: 357: 2562.
33. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999: 13: 266.
34. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990: 49: 201.
35. Hoffmann SC, Kampen RL, Amur S et al. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002: 74: 916.
36. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997: 99: 2682.
37. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991: 87: 2036.
38. Rabb H, Daniels F, O'Donnell M et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000: 279: F525.
39. Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998: 153: 557.
40. Petrinec D, Reilly JM, Sicard GA et al. Insulin-like growth factor-1 attenuates delayed graft function in a canine renal autotransplantation model. Surgery 1996: 120: 221.
41. Hladunewich MA, Corrigan G, Derby GC et al. A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. Kidney Int 2003: 64: 593.
42. Hirschberg R, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999: 55: 2423.
43. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008: 23: 2995.